Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8056 to 8070 of 8908 results

  1. Chronic obstructive pulmonary disease: fluticasone furoate, umeclidinium and vilanterol (Trelegy) (ES18)

    This evidence summary has been updated and replaced by NICE guideline 115.

    Withdrawn advice

  2. Doxylamine/pyridoxine (Xonvea) for treating nausea and vomiting of pregnancy (ES20)

    This evidence summary has been updated and replaced by NICE guideline NG201.

    Withdrawn advice

  3. Antimicrobial prescribing: Ceftazidime/avibactam (ES16)

    This evidence summary has been updated and replaced by NICE antimicrobial health technology evaluation guidance on ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections.  

    Withdrawn advice

  4. Chronic obstructive pulmonary disease: beclometasone, formoterol and glycopyrronium (Trimbow) (ES17)

    This evidence summary has been updated and replaced by NICE guideline 115.

    Withdrawn advice

  5. Oestrogen deficiency symptoms in postmenopausal women: conjugated oestrogens and bazedoxifene acetate (ES3)

    This evidence summary has been withdrawn because the product is no longer available in the UK.

    Withdrawn advice

  6. External aortic root support in Marfan syndrome (IPG394)

    This guidance has been updated and replaced by NICE HealthTech guidance 623.

    Withdrawn guidance

  7. Liposuction for chronic lymphoedema (IPG588)

    This guidance has been updated and replaced by NICE HealthTech guidance 622.

    Withdrawn guidance

  8. Rezum for treating benign prostatic hyperplasia (MIB158)

    This advice has been updated and replaced by NICE medical technologies guidance 49. 

    Withdrawn advice

  9. gammaCore for cluster headache (MIB162)

    This advice has been updated and replaced by NICE medical technologies guidance 46.

    Withdrawn advice

  10. Axonics sacral neuromodulation system for overactive bladder and faecal incontinence (MIB164)

    This advice has been updated and replaced by NICE medical technologies guidance 50.

    Withdrawn advice

  11. Cerebrotech Visor for detecting stroke (MIB165)

    The medtech innovation briefing on Cerebrotech Visor for detecting stroke has been withdrawn as the technology is no longer available in the NHS.

    Withdrawn advice

  12. PICO negative pressure wound therapy for closed surgical incision wounds (MIB149)

    This advice has been updated and replaced by NICE medical technologies guidance 43.

    Withdrawn advice

  13. Eyemax mono for age-related macular degeneration (MIB154)

    We’ve temporarily withdrawn this medtech innovation briefing to correct factual errors in the text.

    Withdrawn advice

  14. NephroCheck test to help assess the risk of acute kidney injury in critically ill patients (MIB156)

    This medtech innovation briefing has been updated and replaced by NICE HealthTech guidance 544.

    Withdrawn advice

  15. Zio Service for detecting cardiac arrhythmias (MIB101)

    This advice has been updated and replaced by NICE healthtech guidance 562.

    Withdrawn advice